Disc Medicine, Inc. logo IRON - Disc Medicine, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $101.60 DETAILS
HIGH: $125.00
LOW: $85.00
MEDIAN: $100.00
CONSENSUS: $101.60
UPSIDE: 26.90%

About Disc Medicine, Inc. (https://www.discmedicine.com)

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Key Executives

NAME TITLE DOB SALARY
John D. Quisel Chief Executive Officer, President & Director 1971 $1,259,763 USD
Jean Franchi Chief Financial Officer 1966 $838,980 USD
William Jacob Savage Chief Medical Officer 1974 $836,840 USD
Pamela Stephenson Chief Commercial Officer 1968 $832,100 USD
Jonathan Yu Chief Opearating Officer 1981 $811,560 USD
Donald William Nicholson Executive Chairman 1958 $170,000 USD
Brian MacDonald Founder & Chair of Scientific Advisory Board 1961 $88,542 USD
Lisa Amaya Price Chief Human Resources Officer
Rahul Khara Chief Legal Officer & Secretary 1982
Rahul Rajan Kaushik Chief Technical Officer
Srikanth Venkatraman Senior Vice President & Head of Chemistry

Company Peers

Peer analysis pending, check back in 1-2 minutes.